Physician

Marcelo Moreira Boek, M.D.

According to 2025 Medicare claims, Marcelo Boek, M.D. (NPI: 1134166788) practices hematology/oncology in the Brownsville-Harlingen, TX market, with the plurality of this provider's patient population coming from Cameron, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 78521-1561.

Boek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 318 traditional Medicare patients, billed 73,449 HCPCS/CPT codes, and received $1,535,982 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,913 prescription claims across 317 beneficiaries totaling $5,233,528 in drug costs, led by Revlimid (Lenalidomide). 2022 DME data shows 36 claims. Open Payments data shows 27 records totaling $906. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,028,759 to $5,233,528. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	545	111,295	$914,466
2016	610	142,150	$1,466,170
2017	689	184,289	$1,736,067
2018	646	164,203	$1,748,373
2019	574	174,752	$2,174,909
2020	468	120,013	$1,443,380
2021	438	121,226	$1,570,138
2022	454	115,004	$1,614,471
2023	369	106,832	$1,529,906
2024	318	73,449	$1,535,982

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	235	1,154	$1,028,759
2016	247	1,296	$1,405,700
2017	243	1,416	$2,193,141
2018	261	1,471	$2,886,290
2019	251	1,500	$3,381,656
2020	274	1,701	$3,639,223
2021	275	1,732	$4,087,269
2022	293	1,724	$4,073,214
2023	297	1,764	$3,827,273
2024	317	1,913	$5,233,528

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	77	$24,356
2016	N/R	48	$13,705
2017	N/R	82	$19,371
2018	N/R	11	$882
2019	N/R	N/R	N/R
2020	N/R	24	$2,653
2021	N/R	39	$4,069
2022	N/R	36	$1,301
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	153	482	$93
80053	Blood test, comprehensive group of blood chemicals	139	379	$10
36415	Insertion of needle into vein for collection of blood sample	129	405	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	140	454	$8
83615	Lactate dehydrogenase (enzyme) level	75	158	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	42	1,176	$786,384
Pomalyst	Pomalidomide	22	609	$518,637
Xtandi	Enzalutamide	37	1,110	$482,512
Calquence	Acalabrutinib Maleate	26	780	$390,815
Ibrance	Palbociclib	22	616	$329,231

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$906	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Marcelo Moreira Boek, M.D.?

Tedicare shows public-source Medicare data for Marcelo Moreira Boek, M.D. (NPI 1134166788), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marcelo Moreira Boek, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marcelo Moreira Boek, M.D.?

Marcelo Moreira Boek, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Marcelo Moreira Boek, M.D. have Open Payments data?

Marcelo Moreira Boek, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.